Konan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device
Shots:
- Konan acquired objectiveFIELD Device from Australian National University (ANU) including 15 issued patents in 9 countries- 6 patients in the process- and clinical data for multiple diagnostic indications and was examined for visual-field manifestations
- The medical device was investigated in Australia for >12 years with >1600 examinations across normal- glaucoma- macular degeneration- diabetic retinopathy- multiple sclerosis- epilepsy- migraine- concussion- and other neuro-vision disorders
- objectiveFIELD is a novel- FDA approved human visual field device used to test both the eyes simultaneously in minutes with no manual efforts- using multi-focal pupil objective perimetry method (mfPOP)
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
